Olive S. Eckstein

May 1, 2024 | acsjournals.onlinelibrary.wiley.com | Kevin Bielamowicz |Peter Dimitrion |Oussama Abla |Simon Bomken |Olive S. Eckstein |Mark Fluchel | +4 more

CONFLICT OF INTEREST STATEMENT Kevin Bielamowicz reports personal/consulting fees from Alexion Pharmaceuticals, SpringWorks Therapeutics, and US WorldMeds LLC outside the submitted work. Matthew Collin reports support for other professional activities from HistioUK outside the submitted work. Eli L. Diamond discloses unpaid editorial support from Pfizer Inc.; and advisory board fees from Day One Therapeutics, Opna Bio, and SpringWorks Therapeutics outside the submitted work.